Cellular Genomics to Use Affy Chips for Kinase Drug Discovery | GenomeWeb

NEW YORK, Oct. 9 (GenomeWeb News) - Drug maker Cellular Genomics will use Affymetrix's GeneChips together with its own Analog Sensitive Kinase Allele technology to develop assays for kinase drug discovery, the companies said today.

The firms also said the collaboration, which is the first of its kind for Affy's DNA chips, will help researchers determine "all the changes in cellular gene expression resulting from exquisitely specific small molecule-mediated human kinase target inhibition."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: modern European bison analysis, phased diploid genome assembly algorithms, and more.

Actress Jennifer Lopez is working with NBC on a CRISPR-inspired television show, according to the Hollywood Reporter.

Researchers trace the origin of one human papillomavirus lineage to Neanderthals or Denisovans, Vox reports.

The BabySeq project faces lower-than-expected enrollment rates, according to ScienceInsider.